Apollo closes €3 billion Bayer capital solution with KKR participation

Verifying
  • Apollo and KKR invested in a new entity holding Bayer’s LARC business.
  • €3 billion was committed through Apollo’s capital solution for Bayer.
  • Bayer retained majority ownership and full operational control of the business.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.